R&D Tax Credit Insights & Analysis

Impact of IRC §280C Elections for R&D Tax Credit Claimants After OBBBA

Understand the tax impact of making a §280C election when claiming the federal R&D tax credit. With the 2025 OBBBA reform and §174A expensing restored, businesses must carefully weigh the benefits of the reduced-credit election versus the gross credit with add-back. This guide breaks down compliance rules, real-world examples, and how to maximize federal and state tax benefits.

Debunking Section 174 Amortization Myths: Avoid R&D Tax Pitfalls

The One Big Beautiful Bill Act (OBBBA), signed into U.S. law on July 4, 2025, repeals Section 174 amortization for domestic R&D expenses, restoring immediate expensing starting in 2025. This change boosts cash flow, strengthens the value of Section 41 R&D tax credits, and supports U.S. businesses investing in innovation. But myths are spreading—about retroactive refunds, foreign R&D, software development, audits, and double-dipping under Section 280C. In this blog, Strike Tax Advisory debunks the top misconceptions, explains who qualifies for retroactive expensing (including the $31M small business threshold), and shows how startups and established companies can maximize credits, deductions, and hiring potential under OBBBA. If you’re searching for clear answers on “OBBBA Section 174 repeal,” “R&D tax credit myths 2025,” or “how to claim retroactive R&D deductions,” this guide breaks it down step by step.

House Passes OBBBA, Reinstates Immediate R&D Expensing

The U.S. House has passed the One Big Beautiful Bill Act (OBBBA), officially repealing Section 174 amortization and restoring immediate expensing for domestic R&D costs. This landmark change means small businesses (with under $31 million in annual gross receipts) can retroactively amend 2022–2024 tax returns to claim full deductions and receive refunds for previously amortized R&D expenses. Larger businesses can accelerate remaining deductions in 2025 and 2026. Foreign R&D costs must still be amortized over 15 years. With immediate expensing back, the Section 41 R&D Tax Credit becomes more valuable, unlocking significant cash flow and refund opportunities for innovative companies. Businesses should act quickly to amend returns and maximize their tax benefits under the new law.

Senate Approves OBBBA with Section 174 R&E Relief

The U.S. Senate has passed the One Big Beautiful Bill Act (OBBBA), delivering retroactive Section 174 R&E tax relief for small and medium-sized enterprises (SMEs). This landmark legislation allows qualifying businesses to immediately expense domestic research and experimental costs back to 2022, potentially unlocking millions in tax savings and boosting innovation. The bill now moves to the House of Representatives, where its retroactive relief provisions will be debated. SMEs are encouraged to consult tax experts, monitor legislative updates, and use StrikeTax’s R&D Tax Credit Calculator to maximize benefits. For ongoing updates and expert guidance, visit StrikeTax.com.

Section 174 Repeal: Big Win for SMEs in Senate Tax Reform

The Senate’s latest tax reform proposal includes a potential repeal of Section 174 amortization, offering SMEs the opportunity for immediate expensing of domestic R&D costs and retroactive tax benefits if enacted. This blog explains what will change, how SMEs can prepare, and what to watch for as the bill moves through Congress. Stay informed and ready to maximize your R&D tax savings if the new law is passed.

Pending 2025 Tax Bill Promises Section 174 Repeal

2025 tax bill draft document with Section 174 repeal highlighted for R&D tax relief.

2025 IRS Form 6765 Updates: Maximize R&D Tax Credits

The 2025 IRS Form 6765, used to claim R&D tax credits, introduces stricter reporting requirements.

Section 174 Relief: Estes’ R&D Bill Boosts Innovation in 2025

The Estes American Innovation and R&D Competitiveness Act offers a clear fix for Section 174’s innovation drag—immediate expensing, retroactive relief, likely resulting in major economic lift.

Section 174 Repeal Update: How OBBBA Section 174A Restored Immediate R&D Expensing

Section 174 amortization was repealed by OBBBA in July 2025. New Section 174A restores immediate domestic R&D expensing for tax years beginning after December 31, 2024. Eligible small businesses can amend 2022, 2023, and 2024 returns retroactively under Rev. Proc. 2025-28, with a deadline of July 6, 2026 or the Section 6511 statute of limitations, whichever is earlier. Here is what to do next.

Claim 2021 R&D Tax Credits Before the Deadline

Time is running out to claim your 2021 R&D tax credits before the 2025 deadline! These credits can reduce tax liabilities, improve cash flow, and support innovation, but after the deadline, the opportunity will be gone. The good news? Section 174 amortization rules don’t apply to 2021 claims, allowing businesses to fully deduct R&D expenses. Eligible activities include software development, prototyping, testing, and more. Act now to secure these valuable tax savings and ensure your business stays competitive!

Game-Changing Tax Reform Ahead? What Every American Business Owner Should Know About R&D Tax Changes

Recent Republican political victories create potential for changes to Section 174 R&D tax treatment. Currently, businesses must capitalize/amortize costs over 5/15 years. Reform could reintroduce immediate expensing, improving cash flow and competitiveness. However, any changes depend on the legislative process and broader economic priorities. Businesses should monitor developments, consult experts, review R&D strategies, and maintain documentation to prepare.

Startup R&D Tax Credit: How Pre-Profit Companies Offset Payroll Taxes in 2026